Thermo Fisher Scientific’s Gibco OncePro Tumoroid Culture Medium Kit was specifically developed for the expansion of patient-derived tumoroids from multiple cancer indications.
Thermo Fisher Scientific’s Gibco OncePro Tumoroid Culture Medium Kit
Thermo Fisher Scientific’s Gibco OncePro Tumoroid Culture Medium Kit is a commercially available culture medium specifically developed for the expansion of patient-derived tumoroids, or cancer organoids, from multiple cancer indications.
As an off-the-shelf modular tumoroid culture medium kit, this product is designed to make it easier for cancer researchers to use patient-derived tumoroids to better model disease and predict patient response to therapeutics in vitro. In an effort to improve ease of use, the kit includes a scalable, automation-compatible suspension culture method.
In addition to the kit, Thermo Fisher Scientific offers Tumoroid Assay Development Services to support outsourced screening and characterization. Customers may also access seven unique OncoPro Tumoroid Cell Lines, representing four different cancer indications including colorectal, lung, endometrial, and breast.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.